India  

Expert: Covishield, Covaxin may offer protection against Omicron

IndiaTimes Tuesday, 30 November 2021
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

India’s GDP grows by 8.4% in the second quarter of Financial Year 2021-22 | Oneindia News [Video]

India’s GDP grows by 8.4% in the second quarter of Financial Year 2021-22 | Oneindia News

India’s GDP grows by 8.4% in July-September; Adar Poonawalla said that children in India should be vaccinated with the Covovax coronavirus vaccine; A new study in the Lancet indicates that the Covishield vaccine against coronavirus remained effective during the Delta variant outbreak; CM Basavaraj Bommai said that the Karnataka government is not looking at any proposal for a statewide lockdown in the wake of the Omicron threat. #GDP #India #Omicron India's GDP grows by 8.4%, Financial Year 2021-22, India’s economic growth, Serum Institute CEO Adar Poonawalla, Covovvax, Vaccination children, Covishield, Lancet study, Delta variant outbreak, Omicron alert, Karnataka CM Basavaraj Bommai, Karnataka government.

Credit: Oneindia    Duration: 02:27Published

Covaxin Covaxin Vaccine against COVID-19

Daily Tarot Card Reading: How to Unlock and Use the Power of Your Subconscious Mind | Oneindia News [Video]

Daily Tarot Card Reading: How to Unlock and Use the Power of Your Subconscious Mind | Oneindia News

The Drugs Controller General of India has approved Bharat Biotech’s Covid 19 vaccines Covaxin for emergency use on children between the ages of 12 and 18. #Covaxin #VaccineforChildren #BharatBiotech

Credit: Oneindia    Duration: 09:12Published
Covaxin approved for children between the age of 12 to 15 years by DGGI | Oneindia News [Video]

Covaxin approved for children between the age of 12 to 15 years by DGGI | Oneindia News

The Drugs Controller General of India has approved Bharat Biotech’s Covid 19 vaccines Covaxin for emergency use on children between the ages of 12 and 18. #Covaxin #VaccineforChildren #BharatBiotech

Credit: Oneindia    Duration: 01:38Published
Covaxin provides only 50 percent protection against Covid-19, says The Lancet | Oneindia News [Video]

Covaxin provides only 50 percent protection against Covid-19, says The Lancet | Oneindia News

A recent study into India’s Covid-19 vaccine, Covaxin suggests that it only gives 50 percent protection against the virus. The study was published in The Lancet Infectious Diseases journal. #Covaxin #Covid-19vaccination #IndiaCovid-19vaccine

Credit: Oneindia    Duration: 02:34Published